Australia markets closed

Q BioMed Inc. (QBIO)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00010.0000 (0.00%)
At close: 02:53PM EST
Full screen
Trade prices are not sourced from all markets
Previous close0.0001
Open0.0001
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0001 - 0.0001
52-week range0.0001 - 0.0179
Volume25,375
Avg. volume125,854
Market cap14,509
Beta (5Y monthly)81.63
PE ratio (TTM)N/A
EPS (TTM)-0.0200
Earnings date26 Feb 2024 - 28 Feb 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Q BioMed Inc. Provides Update to Shareholders

    Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, provides an update to shareholders.

  • PR Newswire

    Q BioMed Inc. Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europe

    Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, asset Uttroside B – has received a patent in the United States and a notice of allowance in Europe, adding to the already issued patents in Korea, Canada and Japan. In addition, recent results from pre-clinical pharmacokinetic testing have been very encouraging and the data supports advancing the program. Uttroside B shows trem